… repurposed as cancer therapeutics (Fig. 1). This review article also includes the clinical trial
status of repurposed drugs, … focused upon for the treatment of various cancer types (Table 1). …

… drug repurposing, we present various promising repurposed non-oncology drugs for clinical
cancer … either mono- or drug combination therapy. We also summarize approaches used for …

… For the other categories of non-cancer drugs, drug development approaches may be … In
summary, drug repurposing has opened a new arena for the development of anticancer drugs as …

… We will discuss how in-silico drug repurposing has the promise to shortly improve our …
that drug repurposing will set more and more stage in the future cancer therapeutics scenario. …

… a major role in the drug development. This article describes … scenario of drug repurposing
for the breast cancer treatment. The … therapeutic areas, such as reusing ovarian cancer drug as …

… In this review we will discuss a number of licensed drug that has the potential to be
repurposed as anti-cancer drugs both in cancer prevention and therapy and highlight some of the …

… associated costs, drug repurposing and drug combinations are … of these therapeutic modalities
for breast cancer therapy is … cancer and, particularly, breast cancer and its therapy. Also, …

… of drug repurposing. In the present review, we are focusing on principles and tools used for
drug repurposing as well … agents/drugs for their repurposing ability against human cancers. …

… in 100+ ongoing Phase II and Phase III clinical trials as a cancer therapeutic (1). Ideal
candidates for drug repurposing are entities that have undergone clinical trials and have been …

… cancer stem cells and their clinical application for cancer treatment. Further, drug repurposing
and the combination of micronutrients that can target both cancers and cancer stem cells …